Risk factors associated with latent tuberculosis infection in Mexican American children

Janine Young1, Mary E O'Connor

  • 1Department of Pediatrics, Denver Health, University of Colorado Health Sciences Center, Denver, Colorado, USA. janine.young@dhha.org

Pediatrics
|June 3, 2005
PubMed

Insights

Latent tuberculosis infection (LTBI) risk factors in Mexican American children include travel to Mexico and Bacille Calmette-Guérin (BCG) vaccination, especially for those born in the U.S. Birth in Mexico was a primary risk factor, with no other significant predictors identified in that group.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology of tuberculosis
  • Public health in immigrant communities

Background:

  • Latent tuberculosis infection (LTBI) poses a significant public health challenge, particularly in pediatric populations within immigrant communities.
  • Identifying specific risk factors for LTBI in Mexican American children is crucial for targeted prevention and control strategies.

Purpose of the Study:

  • To determine the risk factors associated with the presence of latent tuberculosis infection (LTBI) in Mexican American children.
  • To investigate the influence of birthplace, Bacille Calmette-Guérin (BCG) vaccination, and travel history on LTBI prevalence.

Main Methods:

  • A prospective cohort study involving 584 Mexican American children aged 1-18 years.
  • Administration of tuberculin skin tests (TSTs) and a comprehensive risk factor questionnaire.
  • Analysis of demographic data, vaccination history, and travel patterns to and from TB-endemic countries.

Main Results:

  • Overall, 12.4% of children had positive TSTs.
  • For children born in the U.S., risk factors for positive TST included travel to Mexico (OR: 2.8) and BCG vaccination (OR: 8.2). Older age was also a factor (OR: 1.2/year).
  • For children born in Mexico, no additional risk factors beyond birthplace were identified.

Conclusions:

  • In Mexican American children, U.S.-born individuals with a history of BCG vaccination or travel to Mexico showed increased risk for LTBI.
  • For children born in Mexico, LTBI risk was primarily associated with their birthplace.
  • Incentives like grocery coupons are effective in improving participant return rates for TST evaluation.
Abstract

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...